Secret law may activate FDA e-cig regulations by May 17, 2016
Last week, the House Appropriations Committee passed a new amendment to the proposed FDA e-cig regulations that is more business-friendly to the vaping industry. As vape shop owners and e-liquid manufactures sit on pins and needles waiting to see what comes next, most Americans assume that nothing new will occur for several weeks or even months because typically the U.S. government is usually very slow to act. However, a secret, little known government law called the Congressional Review Act might convince Congress and President Obama to put FDA Amendment HR 2058 into effect as early as May 17.
(Related Article: Congress Saves Vaping by Passing FDA Amendment)
The Role of the OIRA and the OMB.
Once the House passed the amendment, the document was sent to the Office of Information and Regulatory Affairs (OIRA) to begin its internal review process. The OIRA is part of the Office of Management and Budget (OMB), the largest office within the Executive Branch of the United States which reports directly to the President. The OIRA can take as long as it wants to come to a decision. But the Congressional Review Act might cause the agency to move faster.
(Related Article: 7 World Class Doctors Blast FRD E-cig Taxes, U.S. Needs to Support Vaping)
The Congressional Review Act
As U.S. Presidents near the end of their term, they become a “Lame Duck” President. Nobody in Congress really expects the President to do much in those last months. But if a President decides to get a little devilish and starts issuing lots of strange Executive Orders that do not require Congressional approval, then the Congressional Review Act gives the next President and Congress the power to revoke those weird regulations almost immediately.
Of course, no one really wants this to happen. It makes the outgoing President look foolish and the new President appear power-hungry. This year, Obama officially becomes a Lame Duck on May 17, 2017, according to the Congressional Review Act.
(Related Article: DNC Chair Schultz Gets Blasted for Opposing FDA Amendment HR 2058)